Cancer Trials Ireland
Budget
€1,782,605
EP Access
0
accredited persons
Staff
2
0.35 FTE
EU Grants
None
Mission & Goals
Our mission is to maximise cancer trial access and outcomes to prolong patient lives and expand cancer research in Ireland. Our vision is to be an indispensable all-Ireland hub for cancer trials, globally recognised for excellence in governance, collaboration and innovation in clinical research. We enable, support and oversee the running of over 100 cancer trials involving thousands of patients.
EU Legislative Interests
-Commission Stakeholder on Europe’s Beating Cancer Plan -European Parliament, Cancer Mission and EU Member States.
Communication Activities
Participation in Commission Stakeholder Contact Group on Europe’s Beating Cancer Plan
Interests Represented
Does not represent commercial interests
Member Of
Breast International Group (BIG) - disbanding in 2026, Eastern Cooperative Oncology (ECOG) and American College of Radiology Imaging Network (ACRIN) Research Group, European Network for Gynaecological Oncological Trials (ENGOT) Group, PrECOG - Sister Foundation of ECOG, European Organisation for Research and Treatment of Cancer (EORTC), European Thoracic Oncology Platform (ETOP) and International Breast Cancer Study Group (IBCSG), German Breast Group (GBG), Gynaecologic Oncology Group (GOG), National Surgical Adjuvant Breast and Bowel Project (NSABP),Swiss Cancer Institute (SCI, formally SAKK).
Organisation Members
Innovative Therapies for Children with Cancer (ITCC), National Cancer Research Network UK (CRUK), (incorporating Cancer Research UK, the Radiation Therapy Oncology Group (RTOG), European Society for Paediatric Oncology (SIOPE), Southwest Oncology Group (SWOG), Translational Research in Oncology (TRIO), Trans-Tasman Radiation Oncology Group (TROG), Canadian Clinical Trials Group (CCTG), Australian Gastrointestinal Trials Group (AGITG).
Commissioner Meetings
No recorded meetings with EU commissioners.